Liz Allen, Director of Strategic Initiatives at F1000 (a provider of services to biomedical researchers); and Michele Garfinkel (Manager of the EMBO Science Policy Programme), analyzed on October 4 at the Science Park of the Universitat de València the changes that scientific policy and communication are undergoing in Open Science. The colloquium, jointly organized by the Institute for Integrative Systems Biology (I2SysBio) and by the Institute of Knowledge and Innovation Management (INGENIO) and with the collaboration of the CSIC, also included a round table on Open Science initiatives.

The scientific meeting inaugurated by José Pío Beltrán, CSIC’s institutional coordinator in the Valencian Community, who  gave presentations to Liz Allen (9.45 h) and Michele Garfinkel (10.30 h).

Round table on Open Science initiatives, starting at 11.45 hours, was formed by José Barrueco, coordinator of Open Access projects at the Universitat de València; and by Remedios Melero (IATA, Institute of Agrochemistry and Food Technologies, CSIC).

Science communication is undergoing a digital revolution that is deeply transforming scientific practices in journals, peer review and data sharing. However, this wave of change also requires transformations in institutional settings, for example, regarding reward systems and social responsibility or integrity. In this colloquium, two world experts at F1000 and EMBO will explore the opportunities and the dangers of Open Science.

Liz Allen is the Director of Strategic Initiatives at F1000. F1000 is a provider of services to biomedical researchers to support the discovery, writing and publication of new scientific findings. Until 2015 Liz was Head of Evaluation at the Wellcome Trust, one of the world’s largest biomedical research charities. During more than a decade at the Wellcome Trust, Liz Allen developed infrastructure to support research governance, progress monitoring and impact assessment, and shapefunding programme evaluations to support research strategy. In 2014 she served as an adviser on the UK government commissioned Independent review of the role of research metrics in research assessment (The Metric Tide).

Michele Garfinkel is the Manager of the EMBO Science Policy Programme where she is responsible for policy research focused on biotechnology and scientific publishing. She is member of the AAAS in recognition of her work looking at the societal impact of molecular biology, synthetic biology and human genomics. The EMBO Science Policy Programme also addresses subjects of concern to scientists and policymakers, including research funding and responsible conduct of research. Until March 2011, she was a policy analyst at the J. Craig Venter Institute. 

More information here (.pdf).